SCHEMBL4745114

SCHEMBL4745114

COc1ccc(NC(c2ccc(OCc3ccccc3)cc2)C(O)C(=O)CCc2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 4/20 0.52
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
FFAR4 Q5NUL3 2/20 0.48
PDE4A P27815 1/20 0.46
PDE4B Q07343 1/20 0.46
PDE4C Q08493 1/20 0.46
PDE4D Q08499 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
PABPC1 P11940 1/20 0.46
ALDH1A1 P00352 1/20 0.46
BCHE P06276 1/20 0.46
POLB P06746 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
LTA4H P09960 3/20 0.45
NPY5R Q15761 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14068463 1.00 FFAR1 (0.52) FFAR1NPC1RAB9ASMN1; SMN2FFAR4
SCHEMBL14068528 0.94 RAB9A (0.51) FFAR1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL4744523 0.94 RAB9A (0.51) FFAR1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL4742525 0.90 MEN1 (0.49) FFAR1NPC1RAB9ASMN1; SMN2FFAR4
SCHEMBL14068292 0.81 CXCL12 (0.47) FFAR1NPC1RAB9AMEN1KMT2A
SCHEMBL4745611 0.78 MEN1 (0.52) FFAR1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL14068553 0.78 MEN1 (0.52) FFAR1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL14104633 0.72 NPY5R (0.44) FFAR1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL8010842 0.72 FFAR1 (0.70) FFAR1FFAR4LTA4H
SCHEMBL1747136 0.70 FFAR1 (0.72) FFAR1NPC1RAB9ASMN1; SMN2FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008104875-A1 OXAZOLIDINONES AS CHOLESTEROL ABSORPTION INHIBITORS PFIZER PRODUCTS INC. (US) 2008-09-04 WO disclosed